Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

NCT: NCT05701098 · COMPLETED

NCT IDNCT05701098
StatusCOMPLETED
Start Date2023-10-09
Completion2025-07-31

Brief Summary

The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a telehealth visit at 2 weeks, and c) return for an imaging study at approximately 10 weeks post-procedure.

Frequently Asked Questions

What is SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)?

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) is a clinical trial registered under NCT05701098. Current status: COMPLETED.

What is the status of NCT05701098?

The current status of NCT05701098 (SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)) is: COMPLETED.

When did SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) start?

SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) started on 2023-10-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑